Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery

ACS Nano

Volumn 7, Issue 8, 2013, Pages 6758-6766

  Gu, Zhen ^a,b,c,d,e   Dang, Tram T ^a,b,c   Ma, Minglin ^a,b,c   Tang, Benjamin C ^a,b,c   Cheng, Hao ^a,b   Jiang, Shan ^a,b   Dong, Yizhou ^a,b,c   Zhang, Yunlong ^a,b,c   Anderson, Daniel G ^a,b,c  

^a USA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d North Carolina 27599 and North Carolina State University   (United States)

^e University of North Carolina at Chapel Hill   (United States)

Author keywords

diabetes; drug delivery; glucose responsive; insulin; microgels; nanocapsules

Indexed keywords

BLOOD GLUCOSE LEVEL; CHITOSAN MATRICES; CLOSED-LOOP INSULIN DELIVERIES; ENZYMATIC CONVERSIONS; ENZYMATIC STABILITY; GLUCOSE-RESPONSIVE; MICRO-GELS; TYPE 1 DIABETES MELLITUS;

CHITOSAN; DRUG DELIVERY; ENZYMES; GLUCOSE; INSULIN; MEDICAL PROBLEMS; NANOCAPSULES;

GELS;

CHITOSAN; DRUG CARRIER; ENZYME; GEL; GLUCONIC ACID; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; NANOCAPSULE; RECOMBINANT PROTEIN;

ANALYSIS; ANIMAL; CATALYSIS; CHEMISTRY; DISEASE MODEL; DRUG DELIVERY SYSTEM; GEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MOUSE; PH; TIME; TRANSMISSION ELECTRON MICROSCOPY; ARTICLE;

ANIMALS; BLOOD GLUCOSE; CATALYSIS; CHITOSAN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENZYMES; GELS; GLUCONATES; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERGLYCEMIA; INSULIN; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOCAPSULES; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 84883208896     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn401617u     Document Type: Article

References (31)

1. Pickup, J. C.; Zhi, Z. L.; Khan, F.; Saxl, T.; Birch, D. J. Nanomedicine and Its Potential in Diabetes Research and Practice Diabetes Metab. Res. Rev. 2008, 24, 604-610
2. Stumvoll, M.; Goldstein, B. J.; van Haeften, T. W. Type 2 Diabetes: Principles of Pathogenesis and Therapy Lancet 2005, 365, 1333-1346
3. Kahn, C. R. Banting Lecture. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes Diabetes 1994, 43, 1066-1084
4. Diabetes Statistics 2012; American Diabetes Association, 2012.
5. Owens, D. R.; Zinman, B.; Bolli, G. B. Insulins Today and Beyond Lancet 2001, 358, 739-746
6. Jeandidier, N.; Boivin, S. Current Status and Future Prospects of Parenteral Insulin Regimens, Strategies and Delivery Systems for Diabetes Treatment Adv. Drug Delivery Rev. 1999, 35, 179-198
7. Owens, D. R. New Horizons-Alternative Routes for Insulin Therapy Nat. Rev. Drug Discovery 2002, 1, 529-540
8. The Diabetes Control and Complications Trial Research Group The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med. 1993, 329, 977-986
9. Bratlie, K. M.; York, R. L.; Invernale, M. A.; Langer, R.; Anderson, D. G. Materials for Diabetes Therapeutics Adv. Healthcare Mater. 2012, 1, 267-284
10. Kumareswaran, K.; Evans, M. L.; Hovorka, R. Artificial Pancreas: An Emerging Approach to Treat Type 1 Diabetes Expert Rev. Med. Devices 2009, 6, 401-410
11. Ravaine, V.; Ancla, C.; Catargi, B. Chemically Controlled Closed-Loop Insulin Delivery J. Controlled Release 2008, 132, 2-11
12. Wu, Q.; Wang, L.; Yu, H. J.; Wang, J. J.; Chen, Z. F. Organization of Glucose-Responsive Systems and Their Properties Chem. Rev. 2011, 111, 7855-7875
13. Podual, K.; Doyle, F. J.; Peppas, N. A. Preparation and Dynamic Response of Cationic Copolymer Hydrogels Containing Glucose Oxidase Polymer 2000, 41, 3975-3983
14. Ishihara, K.; Kobayashi, M.; Ishimaru, N.; Shinohara, I. Glucose-Induced Permeation Control of Insulin through a Complex Membrane Consisting of Immobilized Glucose-Oxidase and a Poly(Amine) Polym. J. 1984, 16, 625-631
15. Makino, K.; Mack, E. J.; Okano, T.; Kim, S. W. A Microcapsule Self-Regulating Delivery System for Insulin J. Controlled Release 1990, 12, 235-239
16. Gordijo, C. R.; Koulajian, K.; Shuhendler, A. J.; Bonifacio, L. D.; Huang, H. Y.; Chiang, S.; Ozin, G. A.; Giacca, A.; Wu, X. Y. Nanotechnology-Enabled Closed Loop Insulin Delivery Device: In Vitro and in Vivo Evaluation of Glucose-Regulated Insulin Release for Diabetes Control Adv. Funct. Mater. 2011, 21, 73-82
17. Kataoka, K.; Miyazaki, H.; Bunya, M.; Okano, T.; Sakurai, Y. Totally Synthetic Polymer Gels Responding to External Glucose Concentration: Their Preparation and Application to On-Off Regulation of Insulin Release J. Am. Chem. Soc. 1998, 120, 12694-12695
18. Kataoka, K.; Miyazaki, H.; Okano, T.; Sakurai, Y. Sensitive Glucose-Induced Change of the Lower Critical Solution Temperature of Poly[N,N-dimethylacrylamide-co-3-(acrylamido)phenyl-boronic acid] in Physiological Saline Macromolecules 1994, 27, 1061-1062
19. Wu, W. T.; Mitra, N.; Yan, E. C. Y.; Zhou, S. Q. Multifunctional Hybrid Nanogel for Integration of Optical Glucose Sensing and Self-Regulated Insulin Release at Physiological pH ACS Nano 2010, 4, 4831-4839
20. Matsumoto, A.; Ishii, T.; Nishida, J.; Matsumoto, H.; Kataoka, K.; Miyahara, Y. A Synthetic Approach Toward a Self-Regulated Insulin Delivery System Angew. Chem., Int. Ed. 2012, 51, 2124-2128
21. Kim, H.; Kang, Y. J.; Kang, S.; Kim, K. T. Monosaccharide-Responsive Release of Insulin from Polymersomes of Polyboroxole Block Copolymers at Neutral pH J. Am. Chem. Soc. 2012, 134, 4030-4033
22. Fischel-Ghodsian, F.; Brown, L.; Mathiowitz, E.; Brandenburg, D.; Langer, R. Enzymatically Controlled Drug Delivery Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 2403-2406
23. Traitel, T.; Cohen, Y.; Kost, J. Characterization of Glucose-Sensitive Insulin Release Systems in Simulated in Vivo Conditions Biomaterials 2000, 21, 1679-1687
24. Podual, K.; Doyle, F. J.; Peppas, N. A. Glucose-Sensitivity of Glucose Oxidase-Containing Cationic Copolymer Hydrogels Having Poly(ethylene glycol) Grafts J. Controlled Release 2000, 67, 9-17
25. Yan, M.; Ge, J.; Liu, Z.; Ouyang, P. Encapsulation of Single Enzyme in Nanogel with Enhanced Biocatalytic Activity and Stability J. Am. Chem. Soc. 2006, 128, 11008-11009
26. Kumar, M. N.; Muzzarelli, R. A.; Muzzarelli, C.; Sashiwa, H.; Domb, A. J. Chitosan Chemistry and Pharmaceutical Perspectives Chem. Rev. 2004, 104, 6017-6084
27. Chakraborty, S.; Liao, I. C.; Adler, A.; Leong, K. W. Electrohydrodynamics: A Facile Technique to Fabricate Drug Delivery Systems Adv. Drug Delivery Rev. 2009, 61, 1043-1054
28. Yan, M.; Du, J.; Gu, Z.; Liang, M.; Hu, Y.; Zhang, W.; Priceman, S.; Wu, L.; Zhou, Z. H.; Liu, Z. et al. A Novel Intracellular Protein Delivery Platform Based on Single-Protein Nanocapsules. Nat. Nanotechnol. 2010, 5, 48-53.
29. Gu, Z.; Yan, M.; Hu, B.; Joo, K. I.; Biswas, A.; Huang, Y.; Lu, Y.; Wang, P.; Tang, Y. Protein Nanocapsule Weaved with Enzymatically Degradable Polymeric Network Nano Lett. 2009, 9, 4533-4538
30. Gu, Z.; Aimetti, A. A.; Wang, Q.; Dang, T. T.; Zhang, Y.; Veiseh, O.; Cheng, H.; Langer, R. S.; Anderson, D. G. Injectable Nano-Network for Glucose-Mediated Insulin Delivery ACS Nano 2013, 7, 4194-4201
31. Konrad, R. J.; Mikolaenko, I.; Tolar, J. F.; Liu, K.; Kudlow, J. E. The Potential Mechanism of the Diabetogenic Action of Streptozotocin: Inhibition of Pancreatic Beta-Cell O -GlcNAc-Elective N -acetyl-Beta- D -Glucosaminidase Biochem. J. 2001, 356, 31-41